A Case of Alpha-Fetoprotein-Producing Adenocarcinoma of the Esophagogastric Junction in which Long-Term Survival Was Achieved by Means of Individualized Multidisciplinary Therapy

[1]  L. Jamil,et al.  Liver metastasis from hepatoid adenocarcinoma of the esophagus mimicking hepatocellular carcinoma , 2015, Gastroenterology report.

[2]  S. Clasen,et al.  AFP-producing adenocarcinoma of the esophagogastric junction: report of a case with atypical immunohistochemical findings responding to palliative chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT regime) , 2016, Zeitschrift für Gastroenterologie.

[3]  T. Yoshikawa,et al.  Mediastinal lymph node metastasis and recurrence in adenocarcinoma of the esophagogastric junction. , 2015, Surgery.

[4]  T. Yoshikawa,et al.  Ten‐year follow‐up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia , 2015, The British journal of surgery.

[5]  M. Okajima,et al.  [A case of AFP-producing esophagogastric junction cancer with liver metastases with a good response to chemotherapy]. , 2014, Gan to kagaku ryoho. Cancer & chemotherapy.

[6]  T. Yoshikawa,et al.  Theoretical therapeutic impact of lymph node dissection on adenocarcinoma and squamous cell carcinoma of the esophagogastric junction , 2014, Gastric Cancer.

[7]  Deng-Chyang Wu,et al.  A case of alpha‐fetoprotein‐producing esophageal adenocarcinoma , 2013, The Kaohsiung journal of medical sciences.

[8]  T. Yoshikawa,et al.  Adenocarcinoma of the esophagogastric junction: incidence, characteristics, and treatment strategies , 2010, Gastric Cancer.

[9]  H. Katai,et al.  Long‐term results of gastrectomy for α‐fetoprotein‐producing gastric cancer , 2010, The British journal of surgery.

[10]  R. Hofheinz,et al.  Alpha-fetoprotein expressing metastastic adenocarcinoma of the esophago-gastric junction responding favorably to capecitabine and oxaliplatin. , 2009, Anti-cancer drugs.

[11]  Kazunori Otsuka,et al.  AFP-producing hepatoid adenocarcinoma in association with Barrett's esophagus with multiple liver metastasis responding to paclitaxel/CDDP: a case report. , 2005, Anticancer research.

[12]  M. Feith,et al.  Biologic and clinical variations of adenocarcinoma at the esophago–gastric junction: Relevance of a topographic‐anatomic subclassification , 2005, Journal of surgical oncology.

[13]  T. Oda,et al.  Alpha-fetoprotein Producing Adenocarcinoma of Esophagogastric Junction: A Case Report , 2005 .

[14]  S. Kitano,et al.  AFP-Producing Gastric Carcinoma: Multivariate Analysis of Prognostic Factors in 270 Patients , 2003, Oncology.

[15]  Paul Fockens,et al.  Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. , 2002, The New England journal of medicine.

[16]  K. Saigenji,et al.  Hepatoid adenocarcinoma in Barrett’s esophagus associated with achalasia: First case report , 2002, Pathology international.

[17]  M. Tsuneyoshi,et al.  Hepatoid adenocarcinoma of the stomach. A clinicopathologic and immunohistochemical analysis , 1993, Cancer.

[18]  N. Nagasue,et al.  Comparison between the clinicopathologic features of AFP-positive and AFP-negative gastric cancers. , 1992, The American journal of gastroenterology.

[19]  N. Nagasue,et al.  Clinicopathologic features and long-term results of alpha-fetoprotein-producing gastric cancer. , 1990, The American journal of gastroenterology.

[20]  D. Gitlin,et al.  Synthesis of -fetoprotein by liver, yolk sac, and gastrointestinal tract of the human conceptus. , 1972, Cancer research.